- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 78 results
Article · Source: Bloomberg Law
September 17, 2023
The Trial Lawyers’ View of Event-Driven Securities Litigation
Client Alert
June 28, 2023
FDA Finalizes Its Premarket Submissions Guidance for Medical Device Software Functions
Article · Source: CEP Magazine
June 1, 2023
ESG and securities litigation: An increased focus on allegations of "greenwashing"
Client Alert
Client Alert
March 2, 2023
The Gathering Storm Over Gas Stoves
Client Alert
February 2, 2023
It’s Not Just for Dietary Supplements Anymore: FTC Revises and Expands Guidance for Health Claims
Client Alert
January 23, 2023
2022 Year in Review: FDA Drug and Device Advertising and Promotion Enforcement
Client Alert
November 14, 2022
FDA (Finally!) Issues Proposed Rule to Amend FDA Regulations on the Protection of Human Subjects and Institutional Review Boards
Article · Source: Pratt’s Privacy & Cybersecurity Law Report
July 1, 2022
First False Claims Act Cases Since Justice Department Launched Its Cybersecurity Initiative Settle
Client Alert
June 28, 2022
California's 2022 Proposed Labor and Employment Laws - Pending Legislation that Employers Should Monitor
Client Alert
June 6, 2022
US EPA Releases Guidance on Legal Tools to Advance Environmental Justice
Client Alert
May 16, 2022
Cooperation Credit and Attorney-Client Privilege: The Implications of Coburn